54 related articles for article (PubMed ID: 1479695)
1. [Burkitt's lymphoma diagnosed by molecular analysis of DNA from malignant cells in ascites].
Murata T; Harano H; Hashimoto Y; Matuzaki M; Mouri H; Kudoh J; Shimizu N; Okubo T
Rinsho Ketsueki; 1992 Dec; 33(12):1834-8. PubMed ID: 1479695
[TBL] [Abstract][Full Text] [Related]
2. The intron enhancer of the immunoglobulin kappa gene activates c-myc but does not induce the Burkitt-specific promoter shift.
Polack A; Strobl L; Feederle R; Schweizer M; Koch E; Eick D; Wiegand H; Bornkamm GW
Oncogene; 1991 Nov; 6(11):2033-40. PubMed ID: 1945409
[TBL] [Abstract][Full Text] [Related]
3. [Burkitt's lymphoma occurring as a primary lymphomatous effusion].
Satoh S; Saito T; Akiba J; Kato Y; Suzuki K; Yoshino M; Tajima K; Hayashi T; Kato T
Rinsho Ketsueki; 2000 Apr; 41(4):329-33. PubMed ID: 10846464
[TBL] [Abstract][Full Text] [Related]
4. Rearrangements of c-myc and c-abl genes in tumour cells in Burkitt's lymphoma.
Casares S; Rodríguez JM; Martin A; Parrado A
J Clin Pathol; 1993 Aug; 46(8):778-9. PubMed ID: 8408711
[TBL] [Abstract][Full Text] [Related]
5. The distinction between Burkitt lymphoma and diffuse large B-Cell lymphoma with c-myc rearrangement.
Nakamura N; Nakamine H; Tamaru J; Nakamura S; Yoshino T; Ohshima K; Abe M
Mod Pathol; 2002 Jul; 15(7):771-6. PubMed ID: 12118116
[TBL] [Abstract][Full Text] [Related]
6. [Diffuse large B-cell lymphoma mainly involving the heart and showing t(8;14) (q24;q32) with c-myc rearrangement].
Takai K; Sanada M; Hirose Y; Shibuya H
Rinsho Ketsueki; 1997 Sep; 38(9):757-62. PubMed ID: 9364867
[TBL] [Abstract][Full Text] [Related]
7. Homogeneous immunophenotype and paucity of secondary genomic aberrations are distinctive features of endemic but not of sporadic Burkitt's lymphoma and diffuse large B-cell lymphoma with MYC rearrangement.
Barth TF; Müller S; Pawlita M; Siebert R; Rother JU; Mechtersheimer G; Kitinya J; Bentz M; Möller P
J Pathol; 2004 Aug; 203(4):940-5. PubMed ID: 15258997
[TBL] [Abstract][Full Text] [Related]
8. [Molecular analysis in Argentinian patients with Burkitt's lymphoma].
Gutiérrez MI; Barriga F; Díez B; Larripa I; Magrath I
Sangre (Barc); 1990 Feb; 35(1):10-4. PubMed ID: 2159189
[TBL] [Abstract][Full Text] [Related]
9. Differences between Burkitt's lymphomas and mouse plasmacytomas in the immunoglobulin heavy chain/c-myc recombinations that occur in their chromosomal translocations.
Müller JR; Janz S; Potter M
Cancer Res; 1995 Nov; 55(21):5012-8. PubMed ID: 7585544
[TBL] [Abstract][Full Text] [Related]
10. Establishment of Epstein-Barr virus-negative diffuse large cell lymphoma cell line with an 8;22 chromosomal translocation.
Ichinose I; Nakano S; Ohshima K; Mitsugi K; Anzai K; Shida T; Niho Y
Cancer Res; 1991 Oct; 51(19):5392-7. PubMed ID: 1913659
[TBL] [Abstract][Full Text] [Related]
11. Combined polymerase chain reaction methods to detect c-myc/IgH rearrangement in childhood Burkitt's lymphoma for minimal residual disease analysis.
Busch K; Borkhardt A; Wössmann W; Reiter A; Harbott J
Haematologica; 2004 Jul; 89(7):818-25. PubMed ID: 15257933
[TBL] [Abstract][Full Text] [Related]
12. [A case of Burkitt's lymphoma with total ophthalmoplegia].
Fukui K; Takeda S; Sadamoto K; Koike S; Okabe K; Toki H; Moriwaki S
No Shinkei Geka; 1985 Nov; 13(11):1183-9. PubMed ID: 4088440
[TBL] [Abstract][Full Text] [Related]
13. Two antisense promoters in the immunoglobulin mu-switch region drive expression of c-myc in the Burkitt's lymphoma cell line BL67.
Apel TW; Mautner J; Polack A; Bornkamm GW; Eick D
Oncogene; 1992 Jul; 7(7):1267-71. PubMed ID: 1620543
[TBL] [Abstract][Full Text] [Related]
14. [Rearrangement of the proto-oncogene c-myc in fresh cells from Burkitt's leukemia (L3)].
Mathieu-Mahul D; Bernheim A; Berger R; Mauchauffe M; Flandrin G; Larsen CJ
Nouv Rev Fr Hematol (1978); 1985; 27(3):157-61. PubMed ID: 2993997
[TBL] [Abstract][Full Text] [Related]
15. The role of immunoglobulin kappa elements in c-myc activation.
Hörtnagel K; Mautner J; Strobl LJ; Wolf DA; Christoph B; Geltinger C; Polack A
Oncogene; 1995 Apr; 10(7):1393-401. PubMed ID: 7731690
[TBL] [Abstract][Full Text] [Related]
16. Theophylline induced differentiation provides direct evidence for the deregulation of c-myc in Burkitt's lymphoma and suggests participation of immunoglobulin enhancer sequences.
Sandlund JT; Neckers LM; Schneller HE; Woodruff LS; Magrath IT
Cancer Res; 1993 Jan; 53(1):127-32. PubMed ID: 8416737
[TBL] [Abstract][Full Text] [Related]
17. Primary gastric Burkitt's lymphoma presenting with c-myc gene rearrangement.
Andoh A; Takaya H; Bamba M; Sakumoto H; Inoue T; Tujikawa T; Koyama S; Fujiyama Y; Bamba T
J Gastroenterol; 1998 Oct; 33(5):710-5. PubMed ID: 9773936
[TBL] [Abstract][Full Text] [Related]
18. Absence of a paused transcription complex from the c-myc P2 promoter of the translocation chromosome in Burkitt's lymphoma cells: implication for the c-myc P1/P2 promoter shift.
Strobl LJ; Kohlhuber F; Mautner J; Polack A; Eick D
Oncogene; 1993 Jun; 8(6):1437-47. PubMed ID: 8502472
[TBL] [Abstract][Full Text] [Related]
19. Topological organization of the MYC/IGK locus in Burkitt's lymphoma cells assessed by nuclear halo preparations.
Rätsch A; Joos S; Kioschis P; Lichter P
Exp Cell Res; 2002 Feb; 273(1):12-20. PubMed ID: 11795942
[TBL] [Abstract][Full Text] [Related]
20. Effusion cytology in Burkitt's lymphoma.
Haddad MG; Silverman JF; Joshi VV; Geisinger KR
Diagn Cytopathol; 1995 Feb; 12(1):3-7. PubMed ID: 7789242
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
